Related Experiment Videos
Ipilimumab and its toxicities: a multidisciplinary approach
Leslie A Fecher1, Sanjiv S Agarwala, F Stephen Hodi
1University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, USA. lafecher@iu.edu
The Oncologist
|June 19, 2013
Summary
Ipilimumab immunotherapy improves survival for metastatic melanoma patients. Early recognition and management of immune-related adverse events (irAEs) are crucial for optimal care.
Area of Science:
- Oncology
- Immunotherapy
- Dermatology
Background:
- Metastatic melanoma treatment has advanced, with immunotherapy becoming a standard of care.
- Ipilimumab, a key immunotherapy, has demonstrated improved overall survival in clinical trials.
- Emerging immune modulating agents like PD-1 and PD-L1 antibodies show early promise.
Purpose of the Study:
- To review the immunotherapy drug ipilimumab and its associated side effects.
- To discuss the recognition, presentation, and management of immune-related adverse events (irAEs).
- To highlight the importance of multidisciplinary teams and patient education in managing irAEs.
Main Methods:
- Review of current literature on ipilimumab and immune-related adverse events.
- Analysis of randomized clinical trial data regarding ipilimumab efficacy and safety.
- Synthesis of recommendations for the workup and management of irAEs.
Main Results:
- Ipilimumab has significantly improved overall survival in metastatic melanoma.
- Immune-related adverse events (irAEs) are common and require early identification.
- Effective management strategies for irAEs are essential for patient care.
Conclusions:
- Ipilimumab is an established treatment for metastatic melanoma, offering survival benefits.
- Proactive monitoring and management of irAEs are critical.
- A collaborative, multidisciplinary approach and patient education are recommended for optimal outcomes.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...